Mabion S.A. (WSE:MAB)
9.57
-0.06 (-0.62%)
Jul 25, 2025, 5:00 PM CET
Mabion Revenue
Mabion had revenue of 2.72M PLN in the quarter ending March 31, 2025, a decrease of -92.01%. This brings the company's revenue in the last twelve months to 37.76M, down -74.16% year-over-year. In the year 2024, Mabion had annual revenue of 69.02M, down -54.50%.
Revenue (ttm)
37.76M
Revenue Growth
-74.16%
P/S Ratio
4.10
Revenue / Employee
179.81K
Employees
213
Market Cap
154.67M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 69.02M | -82.66M | -54.50% |
Dec 31, 2023 | 151.68M | -12.30M | -7.50% |
Dec 31, 2022 | 163.98M | 127.92M | 354.72% |
Dec 31, 2021 | 36.06M | - | - |
Dec 31, 2020 | - | - | - |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
NEUCA | 12.82B |
Voxel | 556.98M |
Synektik Spólka Akcyjna | 592.94M |
Celon Pharma | 215.11M |
Ryvu Therapeutics | 97.57M |
Selvita | 359.79M |
Centrum Medyczne ENEL-MED | 762.83M |
Mercator Medical | 559.42M |